Prostaglandin E₂ Produced by Alginate-Encapsulated Mesenchymal Stromal Cells Modulates the Astrocyte Inflammatory...

Area of Science:

• Neuroscience
• Cell Biology
• Biomaterials Science

Background:

• Astroglia play a key role in secondary brain injury propagation.
• Mesenchymal stromal cells (MSCs) show therapeutic potential but struggle with persistence at injury sites.
• Alginate microsphere encapsulation offers a strategy for sustained MSC delivery.

Purpose of the Study:

• To evaluate the efficacy of encapsulated MSCs in attenuating neuro-inflammation.
• To compare the anti-inflammatory effects of encapsulated MSCs versus monolayer MSCs.
• To investigate the role of MSC-produced prostaglandin E2 (PGE2) in modulating astrocyte responses.

Main Methods:

• Co-culture of LPS-stimulated astroglial cells with encapsulated or monolayer human MSCs.
• Quantification of pro-inflammatory cytokine TNF-α produced by astroglia.
• Measurement of MSC-produced PGE2 and expression of neurotrophin-associated genes.

Main Results:

• Encapsulated MSCs significantly reduced TNF-α production by LPS-stimulated astrocytes more effectively and earlier than monolayer MSCs.
• Encapsulated MSCs constitutively produced high levels of PGE2, which was crucial for early TNF-α reduction.
• MSC-produced PGE2 also stimulated astrocyte neurotrophin production.

Conclusions:

• Alginate encapsulation enhances MSCs' therapeutic benefits for neuro-inflammation and neuroprotection.
• Early, sustained delivery of MSCs via encapsulation is key for modulating inflammatory cascades.
• Encapsulated MSCs offer a promising approach for treating central nervous system injuries.